CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 78993 | LVS EN ISO 10993-23:2021/A1:2025 | Biological evaluation of medical devices - Part 23: Tests for irritation - Amendment 1: Additional in vitro reconstructed human epidermis models (ISO 10993-23:2021/Amd 1:2025) | Standarts spēkā |
| 68925 | LVS EN ISO 10993-23:2021 | Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021) | Standarts spēkā |
| 69998 | LVS EN ISO 10993-2:2023 | Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022) | Standarts spēkā |
| 22132 | LVS EN ISO 10993-2:2006 | Biological evaluation of medical devices - Part 2: Animal welfare requirements | Atcelts |
| 9484 | LVS EN ISO 10993-2:2000 | Biological evaluation of medical devices - Part 2: Animal welfare requirements | Atcelts |
| 74131 | LVS EN ISO 10993-18:2020/A1:2023 | Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Amendment 1: Determination of the uncertainty factor (ISO 10993-18:2020/Amd 1:2022) | Standarts spēkā |
| 60725 | LVS EN ISO 10993-18:2020 | Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020) | Standarts spēkā |
| 32004 | LVS EN ISO 10993-18:2009 | Biological evaluation of medical devices - Part 18: Chemical characterization of materials (ISO 10993-18:2005) | Atcelts |
| 9500 | LVS EN ISO 10993-18:2005 | Biological evaluation of medical devices - Part 18: Chemical characterization of materials | Atcelts |
| 78994 | LVS EN ISO 10993-17:2023/A1:2025 | Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents - Amendment 1 (ISO 10993-17:2023/Amd 1:2025) | Standarts spēkā |
Displaying 51-60 of 200 results.